Mesalazine Sandoz (Mesalazine)

Mesalazine works by blocking the cyclooxygenase and lipoxygenase pathways in the gut lining, which lowers the production of prostaglandins and leukotrienes—key mediators of inflammation. It also modulates cytokine release, limiting immune cell activation and promoting healing of the intestinal mucosa.

The exact dose of Mesalazine Sandoz is determined by the prescribing clinician based on the patient’s disease severity, location, and response to therapy. Dosage regimens can vary widely, and the prescriber will tailor the amount and frequency to achieve optimal clinical benefit while minimizing side effects.

Safety data for Mesalazine Sandoz in pregnancy and lactation are limited, and the product’s pregnancy category is listed as unknown. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss potential risks and benefits with their healthcare provider before using this medication.

To request Mesalazine Sandoz, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain needs), and necessary import documentation.

Mesalazine belongs to the 5‑ASA class and is often compared with sulfasalazine, another oral anti‑inflammatory. Compared with sulfasalazine, mesalazine generally has fewer systemic side effects because it delivers the active moiety directly to the colon, but both aim to control inflammation in ulcerative colitis and colonic Crohn’s disease.

Mesalazine Sandoz should be stored at ambient temperature, below 25 °C, in its original packaging to protect it from moisture and light. Keep the product out of reach of children and avoid storing it in bathrooms or other humid environments.

Mesalazine Sandoz is taken orally, usually with a full glass of water. It can be swallowed with or without food, but patients should follow the prescribing information or their clinician’s instructions regarding timing relative to meals to ensure consistent absorption.

Serious adverse events, although rare, include myocarditis, severe liver injury, pancreatitis, blood dyscrasias such as neutropenia, and life‑threatening allergic reactions like anaphylaxis. Patients should seek immediate medical attention if they experience chest pain, jaundice, severe abdominal pain, unexplained fever, or signs of an allergic reaction.

Mesalazine Sandoz is contraindicated in individuals with a known hypersensitivity to mesalazine, 5‑ASA compounds, or any of the excipients in the formulation. Patients with severe renal or hepatic impairment should use it only under close medical supervision, and those with a history of myocarditis should avoid it.